CTKB vs JNPR · rev $92.3M vs P/E 38, $13.36B cap
Cytek Biosciences Inc (CTKB) versus Juniper Networks Inc (JNPR) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
JNPR does not have a complete income-statement cache yet.
CTKB currently screens at market cap $421.8M. JNPR currently screens at market cap $13.36B and trailing P/E 38.0.
Not investment advice. Open the CTKB and JNPR stock pages for the full models.
Not investment advice.